Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,174.70
-5.30 (-0.45%)
Aug 21, 2026, 3:15 PM IST
Dr. Reddy's Laboratories Stock Forecast
Stock Price Forecast
According to 39 analysts polled by S&P Global, Dr. Reddy's Laboratories stock has a consensus rating of "Hold" and an average price target of ₹1,266. The average 1-year stock price forecast is 7.75% higher than the current stock price, while the lowest is ₹1,039 (-11.55%) and the highest is ₹1,740 (+48.12%).
Price Target: ₹1,266 (+7.75%)
Analyst Consensus: Hold
Price Target
Chart* Price targets were last updated on Apr 23, 2026.
Analyst Ratings
The average analyst rating for Dr. Reddy's Laboratories stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 12 | 11 | 12 | 12 | 11 | 11 |
| Buy | 4 | 4 | 5 | 5 | 4 | 4 |
| Hold | 10 | 10 | 10 | 10 | 11 | 11 |
| Sell | 7 | 7 | 6 | 6 | 8 | 8 |
| Strong Sell | 5 | 6 | 6 | 6 | 6 | 5 |
| Total | 38 | 38 | 39 | 39 | 40 | 39 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Goldman Sachs | Goldman Sachs | Sell Downgrades ₹1,075 | Sell | Downgrades | ₹1,075 | -8.49% | Apr 23, 2026 |
Unknown Analyst Geojit Research No rating | Geojit Research | Hold Maintains ₹1,390 | Hold | Maintains | ₹1,390 | +18.33% | Feb 24, 2026 |
Financial Forecast
Revenue This Year
351.91B
from 335.93B
Increased by 4.76%
Revenue Next Year
392.78B
from 351.91B
Increased by 11.61%
EPS This Year
44.71
from 55.39
Decreased by -19.29%
EPS Next Year
59.39
from 44.71
Increased by 32.85%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.